Industry
Pharmaceutical Wholesale Distributors
GDP audit and compliance assessment services for licensed wholesale dealers, 3PL providers, parallel importers and cold chain operators, aligned to EU GDP Guidelines and MHRA requirements.
The Distribution Compliance Environment
Pharmaceutical wholesale distribution is regulated across the EU and UK by GDP Guidelines that establish requirements for storage, transport, documentation, personnel, quality management and supply chain integrity. Licensed wholesale dealers are subject to inspection by national competent authorities and must maintain compliance with these requirements as a condition of their wholesale dealer licence.
Distribution quality failures have direct consequences for product integrity and patient safety. Temperature excursions during storage or transport can compromise product quality without affecting product appearance, making distribution quality failures particularly difficult for patients and prescribers to identify. GDP compliance is therefore not merely a regulatory formality but a genuine product quality and patient safety requirement.
Sthira Assure GDP audits assess the full scope of distribution quality system requirements, from storage facility qualification and temperature monitoring through supplier and customer qualification, Responsible Person system function, FMD compliance and returns handling. We provide independent assessment that gives organisations confidence in their GDP compliance status before national competent authority inspection.
Key Frameworks
- EU GDP Guidelines 2013
- MHRA GDP Guidance
- FMD 2011/62/EU
- EU Directive 2001/83/EC
- WHO GDP Guidelines
- IATA Guidelines
Discuss Your Requirements
Get in TouchTypical Risk Areas
Storage Condition Compliance
Wholesale distribution facilities must maintain appropriate storage conditions for all pharmaceutical products held on site. GDP inspectors assess whether storage facilities are qualified for their intended purpose, whether temperature monitoring systems are operational and calibrated and whether excursions are investigated and documented. Ambient warehouses must be mapped to demonstrate that all storage zones maintain temperatures within specified limits throughout the year.
Product Authenticity Verification
The Falsified Medicines Directive (FMD) 2011/62/EU requires wholesale dealers to verify the authenticity of medicinal products before supplying them. Implementation of FMD verification at the point of supply, management of decommissioned packs and exception handling processes are consistently assessed during GDP inspections. Organisations that cannot demonstrate FMD compliance face significant regulatory consequences.
Responsible Person Oversight
The Responsible Person is legally accountable for ensuring compliance with GDP requirements and must be actively engaged in the quality system, not a nominal title holder. Inspectors assess whether RP oversight extends to all distribution activities, whether the RP has reviewed and approved relevant procedures and whether RP involvement in quality decisions is documented in quality records.
Returns and Recalls Management
Returns handling under GDP requires that returned medicinal products are not released for resale without prior assessment. The criteria for assessment and the procedures for managing quarantined returns are specific GDP requirements. Inspectors also assess whether recall procedures have been tested and whether organisations can demonstrate rapid, complete product traceability in response to a simulated recall scenario.
Speak with a GDP Audit Specialist
Contact our team to discuss your GDP audit, cold chain compliance or RP system assessment requirements.